Main ERS website
ERS Respiratory Channel
Stay up to date
There is an increased need to address new therapeutic avenues to treat pneumonia caused by infectious agents that no longer respond to standard of care therapies alone (e.g. antibiotics). This webinar discussed the concept of targeted immunomodulation as a means to treat pneumonia, with focus on Toll-Like Receptor agonists and aerosol delivery.
The audience can gain a better understanding of immunomodulation and targeted therapies for pneumonia.
Expert presentations and a Q&A session.
Following this webinar, participants will be able to: